Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

459
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

391
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
391
Drug Therapy01:28

Drug Therapy

385
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
385

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Culture change and lessons learned from ten years in the VA centers of excellence in primary care education.

BMC medical education·2024
Same author

Ultra-rapid insulin in mitochondrial diabetes: Two clinical cases.

Endocrinologia, diabetes y nutricion·2023
Same author

COMBINSI (COMBat to INSufficient Insulin therapy) - A Portuguese project in type 2 diabetes.

Diabetes & metabolic syndrome·2023
Same author

Underprescription of SGLT2i and GLP-1 RA: CAREPRO-T2D (Cardiorenal Protection in Type 2 Diabetes) Cross-Sectional Study.

Cureus·2023
Same author

Portuguese versus Fenton Curve: Which one better explains maternal and neonatal outcomes in Portuguese women with gestational diabetes?

Diabetes & metabolic syndrome·2022
Same author

Clinical features of pheochromocytoma masked by VIP co-secretion.

Endocrinologia, diabetes y nutricion·2022

Related Experiment Video

Updated: Mar 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K

Pharmacologic Therapies in Anticoagulation.

Joana Lima Ferreira1, Joyce E Wipf2

  • 1Division of General Internal Medicine, Department of Medicine, University of Washington Medical Center, 1959 North East Pacific Street, Box 356429, Seattle, WA 98195, USA.

The Medical Clinics of North America
|May 29, 2016
PubMed
Summary

This review covers anticoagulant pharmacology, including vitamin K antagonists, direct oral anticoagulants, and heparins. Understanding these drugs is crucial for effective treatment and minimizing bleeding risks in patients.

Keywords:
AnticoagulationAtrial fibrillationDirect oral anticoagulantsHeparinVenous thromboembolismWarfarin

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

2.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

2.0K

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Hematology

Background:

  • Anticoagulants are vital for managing venous thromboembolism and preventing stroke in atrial fibrillation.
  • The emergence of target-specific oral anticoagulants has significantly advanced anticoagulation therapy.
  • A thorough grasp of anticoagulant pharmacology is essential for optimal patient care and safety.

Purpose of the Study:

  • To review the pharmacology of major anticoagulant classes.
  • To outline the clinical indications for these anticoagulants based on current evidence.
  • To provide a foundation for informed therapeutic decision-making.

Main Methods:

  • Literature review of evidence-based data on anticoagulants.
  • Focus on vitamin K antagonists, direct oral anticoagulants, and heparins.
  • Analysis of pharmacological properties and clinical applications.

Main Results:

  • Detailed review of the mechanisms of action, pharmacokinetics, and pharmacodynamics of key anticoagulant classes.
  • Summary of established clinical indications supported by scientific literature.
  • Highlighting the evolving landscape of anticoagulation with new oral agents.

Conclusions:

  • Understanding anticoagulant pharmacology is fundamental for safe and effective clinical practice.
  • The choice of anticoagulant should be guided by evidence-based indications and patient-specific factors.
  • Continued education on anticoagulant therapies is necessary to optimize patient outcomes and reduce complications.